CpG oligodeoxynucleotides with double stem-loops show strong immunostimulatory activity

International Immunopharmacology

Volumn 15, Issue 1, 2013, Pages 89-96

  Yu, Yongli ^a   Yang, Liang ^a,b   Wu, Xiuli ^a   Wan, Min ^a   Yu, Yue ^a   Wang, Liying ^a  

^a Basic Medical College   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

CpG ODN; TLR9; Tumor immunology

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; B7 ANTIGEN; CD86 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; DOUBLE STEM LOOP OLIGODEOXYNUCLEOTIDE 01; DOUBLE STEM LOOP OLIGODEOXYNUCLEOTIDE 03; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; DOGS; FEMALE; GUINEA PIGS; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; NEOPLASMS; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN STRUCTURE, SECONDARY; RABBITS; RATS; SPLEEN; SWINE; TUMOR BURDEN;

EID: 84872331771     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.10.020     Document Type: Article

References (30)

1. A.M. Krieg Therapeutic potential of Toll-like receptor 9 activation Nat Rev Drug Discov 5 2006 471 484
2. S. Sivori, S. Carlomagno, L. Moretta, and A. Moretta Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells Eur J Immunol 36 2006 961 967
3. A. Krug, S. Rothenfusser, V. Hornung, B. Jahrsdorfer, S. Blackwell, and Z.K. Ballas Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells Eur J Immunol 31 2001 2154 2163
4. D. Verthelyi, K.J. Ishii, M. Gursel, F. Takeshita, and D.M. Klinman Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs J Immunol 166 2001 2372 2377
5. Z.K. Ballas, W.L. Rasmussen, and A.M. Krieg Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA J Immunol 157 1996 1840 1845
6. J. Vollmer, R. Weeratna, P. Payette, M. Jurk, C. Schetter, and M. Laucht Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities Eur J Immunol 34 2004 251 262
7. J.D. Marshall, K. Fearon, C. Abbate, S. Subramanian, P. Yee, and J. Gregorio Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions J Leukoc Biol 73 2003 781 792
8. A.M. Krieg Toll-like receptor 9 (TLR9) agonists in the treatment of cancer Oncogene 27 2008 161 167
9. A.M. Krieg Development of TLR9 agonists for cancer therapy J Clin Invest 117 2007 1184 1194
10. Y.P. Cong, S.S. Song, L. Bhagat, R.K. Pandey, D. Yu, and E.R. Kandimalla Self-stabilized CpG DNAs optimally activate human B cells and plasmacytoid dendritic cells Biochem Biophys Res Commun 310 2003 1133 1139
11. G. Hartmann, J. Battiany, H. Poeck, M. Wagner, M. Kerkmann, and N. Lubenow Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells Eur J Immunol 33 2003 1633 1641
12. E.R. Kandimalla, L. Bhagat, Y.P. Cong, R.K. Pandey, D. Yu, and Q. Zhao Secondary structures in CpG oligonucleotides affect immunostimulatory activity Biochem Biophys Res Commun 306 2003 948 953
13. D. Yu, M.R. Putta, L. Bhagat, M. Dai, D. Wang, and A.F. Trombino Impact of secondary structure of toll-like receptor 9 agonists on interferon alpha induction Antimicrob Agents Chemother 52 2008 4320 4325
14. J.D. Marshall, K.L. Fearon, D. Higgins, E.M. Hessel, H. Kanzler, and C. Abbate Superior activity of the type C class of ISS in vitro and in vivo across multiple species DNA Cell Biol 24 2005 63 72
15. C.C. Wu, J. Lee, E. Raz, M. Corr, and D.A. Carson Necessity of oligonucleotide aggregation for toll-like receptor 9 activation J Biol Chem 279 2004 33071 33078
16. M. Zuker Mfold web server for nucleic acid folding and hybridization prediction Nucleic Acids Res 31 2003 3406 3415
17. M. Bao, Y. Zhang, M. Wan, L. Dai, X. Hu, and X. Wu Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide Clin Immunol 118 2006 180 187
18. J. Ren, L. Sun, L. Yang, H. Wang, M. Wan, and P. Zhang A novel canine favored CpG oligodeoxynucleotide capable of enhancing the efficacy of an inactivated aluminum-adjuvanted rabies vaccine of dog use Vaccine 28 2010 2458 2464
19. D. Li, H. Li, P. Zhang, X. Wu, H. Wei, and L. Wang Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity Eur J Immunol 36 2006 1324 1336
20. S. Sopper, C. Stahl-Hennig, M. Demuth, I.C. Johnston, R. Dorries, and V. ter Meulen Lymphocyte subsets and expression of differentiation markers in blood and lymphoid organs of rhesus monkeys Cytometry 29 1997 351 362
21. N. Kunikata, K. Sano, M. Honda, K. Ishii, J. Matsunaga, and R. Okuyama Peritumoral CpG oligodeoxynucleotide treatment inhibits tumor growth and metastasis of B16F10 melanoma cells J Invest Dermatol 123 2004 395 402
22. Y. Kawarada, R. Ganss, N. Garbi, T. Sacher, B. Arnold, and G.J. Hammerling NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides J Immunol 167 2001 5247 5253
23. K. Heckelsmiller, K. Rall, S. Beck, A. Schlamp, J. Seiderer, and B. Jahrsdorfer Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model J Immunol 169 2002 3892 3899
24. S. Yamamoto, T. Yamamoto, T. Kataoka, E. Kuramoto, O. Yano, and T. Tokunaga Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity J Immunol 148 1992 4072 4076
25. Z. Cong, M. Wan, X. Wu, L. Wang, X. Hu, and F. Yang A CpG oligodeoxynucleotide inducing anti-coxsackie B3 virus activity in human peripheral blood mononuclear cells FEMS Immunol Med Microbiol 51 2007 26 34
26. C. Paget, T. Mallevaey, A.O. Speak, D. Torres, J. Fontaine, and K.C. Sheehan Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids Immunity 27 2007 597 609
27. M. Gursel, D. Verthelyi, I. Gursel, K.J. Ishii, and D.M. Klinman Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide J Leukoc Biol 71 2002 813 820
28. A. Krug, S. Rothenfusser, S. Selinger, C. Bock, M. Kerkmann, and J. Battiany CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells J Immunol 170 2003 3468 3477
29. M. Bauer, V. Redecke, J.W. Ellwart, B. Scherer, J.P. Kremer, and H. Wagner Bacterial CpG-DNA triggers activation and maturation of human CD11c -, CD123 + dendritic cells J Immunol 166 2001 5000 5007
30. T. Maurer, A. Heit, H. Hochrein, F. Ampenberger, M. O'Keeffe, and S. Bauer CpG-DNA aided cross-presentation of soluble antigens by dendritic cells Eur J Immunol 32 2002 2356 2364